Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.

van Lierop, A H

Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment. [electronic resource] - The Journal of clinical endocrinology and metabolism Oct 2012 - E1953-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1945-7197

10.1210/jc.2012-2218 doi


Adaptor Proteins, Signal Transducing
Adrenalectomy
Adult
Animals
Bone Morphogenetic Proteins--blood
Bone Remodeling--physiology
Collagen Type I--blood
Cushing Syndrome--metabolism
Female
Fibroblast Growth Factor-23
Fibroblast Growth Factors--blood
Genetic Markers
Humans
Hydrocortisone--blood
Male
Mice
Middle Aged
Osteocytes--physiology
Peptide Fragments--blood
Peptides--blood
Procollagen--blood